Amgen (AMGN)

$247.72 0.36 (0.15%)

19:54 EDT AMGN Stock Quote Delayed 30 Minutes

Volume:

Previous Close $247.72

Market Cap 163.92B

PE Ratio 78.64

EPS 3.15

Volume (Avg. Vol.) 6.04M

Day's Range 242.35 - 249.84

52-Week Range 177.05 - 264.97

Dividend & Yield 5.28 (2.13%)

AMGN Stock Predictions, Articles, and Amgen News

From InvestorPlace
From the Web

This Company is the Landlord of Life Sciences

By Neil George, Editor, Profitable Investing Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

4 California Stocks to Keep On Hold Until Post-Coronavirus

By Tezcan Gecgil, InvestorPlace Contributor Jul 6, 2020

These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.

This Stock Points to the Massive China Biotech Trend

By Matt McCall, Editor, MoneyWire Apr 23, 2020

There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.

4 Healthcare Stocks to Buy For Coronavirus Innovation

By William Roth, InvestorPlace Market Strategist Apr 17, 2020

As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Mar 16, 2020

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

3 Healthcare Stocks Under Pressure from Bernie

By William Roth, InvestorPlace Market Strategist Jan 27, 2020

These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.

Compare Brokers

3 of the Best Healthcare Stocks to Buy in 2020

By Tyler Craig, Tales of a Technician Jan 2, 2020

Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

By InvestorPlace Staff Dec 27, 2019

Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.

Stock Market Today: New Highs; Buy Micron, Nvidia?

By Bret Kenwell, InvestorPlace Contributor Dec 16, 2019

Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.

3 Healthcare Stocks to Buy Before the End of 2019

By Tyler Craig, Tales of a Technician Dec 9, 2019

The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.

This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma

By Matt McCall, Editor, MoneyWire Nov 8, 2019

Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.

2020 Election Could Hurt Amgen Stock’s Healthy Dividend

By Dana Blankenhorn, InvestorPlace Contributor Nov 5, 2019

The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.

Compare Brokers

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor Sep 27, 2019

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

4 Biotech Stocks to Buy That Are on the Move

By William Roth, InvestorPlace Market Strategist Aug 27, 2019

Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.

Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?

By Zacks Investment Research Aug 27, 2019

Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.

Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks

By Bret Kenwell, InvestorPlace Contributor Aug 26, 2019

Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.

5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY

By Bret Kenwell, InvestorPlace Contributor Aug 26, 2019

Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.

Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen

By William White, InvestorPlace Writer Aug 26, 2019

Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.

Compare Brokers

Wednesday’s Vital Data: Amgen, American Airlines and Apple

By Tyler Craig, Tales of a Technician Aug 14, 2019

Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.